The study shows how important basic research is to our understanding of possible side effects from drug candidates interacting with various target proteins.
The study was done by researchers at Umeå University in Sweden and is published in the latest issue of the prestigious Journal of the American Chemical Society. The findings surprise all the researchers involved.
Fredrik Almqvist, professor of organic chemistry, working with colleagues at Washington University in St. Louis and the University of Michigan in Ann Arbor, has developed a molecule, FN075, that slows down the infection capability of bacteria. This molecule blocks the growth and function of the hair-like shoots that bacteria use to cause infections. Even though the molecule is not used in any drugs today, this disarming principle could be of great importance in future struggles against resistance to antibiotics.
Interestingly, bacteria’s hair-like shoots are structured according to the same principle as amyloid proteins, improperly folded proteins that accumulate in nerve disorders like Parkinson’s and Alzheimer’s diseases.
“So we tested whether FN 075 could also hamper the formation of amyloids in a protein that is implicated in Parkinson’s disease. But instead it turned out that the molecule boosted the formation of amyloid structures,” says Pernilla Wittung-Stafshede, professor of biological chemistry.
In other words, the same tiny molecule can have exactly the opposite effect depending on what protein it encounters and in what surroundings. The study thus shows that it is important to test for possible side effects that new substances might have on amyloid proteins.
“There seems to be a fine balance between what activities these types of substances hamper and what activities they prompt,” says Pernilla Wittung-Stafshede.
She says it is too early to say whether the effects on the amyloid proteins are positive or negative from a medical perspective. On the other hand, it is clear that molecules like FN075 are key research tools to achieve an understanding of these types of complex processes.
The new findings have inspired the researchers regarding how to continue to design and use small molecules that can affect amyloid formation.
“Perhaps some of the body’s own small metabolites help to trigger amyloid formation in nerve disorders like Parkinson’s and Alzheimer’s,” wonders Fredrik Almqvist, who declares that they will now be following up these findings.
The research is being conducted at the Chemical Biology Centre, KBC, and the Umeå Centre for Microbial Research, UCMR at Umeå University and is based on the combined expertise of the chemists Pernilla Wittung-Stafshede, Magnus Wolf-Watz, and Fredrik Almqvist. Most of the study was carried out by post-doctoral fellows Istvan Horvath, Christoph F. Weise, and Emma Andersson. With the assistance of the KBC platform for nuclear magnetic resonance, NMR, the scientists have been able to study proteins at the atomic level.For more information, please contact:
E-mail: firstname.lastname@example.orgFredrik Almqvist, professor of organic chemistry, Department of Chemistry, Chemical Biological Centre, KBC, and Umeå Centre for Microbial Research, UCMR, Umeå University
Small but versatile; key players in the marine nitrogen cycle can utilize cyanate and urea
10.12.2018 | Max-Planck-Institut für Marine Mikrobiologie
Carnegie Mellon researchers probe hydrogen bonds using new technique
10.12.2018 | Carnegie Mellon University
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.
Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...
New Project SNAPSTER: Novel luminescent materials by encapsulating phosphorescent metal clusters with organic liquid crystals
Nowadays energy conversion in lighting and optoelectronic devices requires the use of rare earth oxides.
Scientists have discovered the first synthetic material that becomes thicker - at the molecular level - as it is stretched.
Researchers led by Dr Devesh Mistry from the University of Leeds discovered a new non-porous material that has unique and inherent "auxetic" stretching...
Scientists from the Theory Department of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science (CFEL) in Hamburg have shown through theoretical calculations and computer simulations that the force between electrons and lattice distortions in an atomically thin two-dimensional superconductor can be controlled with virtual photons. This could aid the development of new superconductors for energy-saving devices and many other technical applications.
The vacuum is not empty. It may sound like magic to laypeople but it has occupied physicists since the birth of quantum mechanics.
10.12.2018 | Event News
06.12.2018 | Event News
03.12.2018 | Event News
10.12.2018 | Life Sciences
10.12.2018 | Physics and Astronomy
10.12.2018 | Life Sciences